Integrated DNA Technologies NBS CF Reagents

The Colorado Newborn Screening Program is seeking to procure Integrated DNA Technologies (IDT) NBS CF Reagents for use in their cystic fibrosis testing. The program has validated the IDT xGen Amplicon CFTR assay and has determined that it is the only vendor that can supply the necessary reagents. The contract term is 5 years, with an estimated dollar amount of $375,000. The program requires the IDT xGen Amplicon CFTR assay due to its compatibility with their existing instrumentation and workflows. Key aspects of the job include: • The procurement of IDT NBS CF Reagents for cystic fibrosis testing • The use of the IDT xGen Amplicon CFTR assay, which is proprietary to IDT • The requirement for the vendor to provide assay optimizations for the NBS blood samples • The need for the vendor to have specific and exclusive experience with the IDT xGen Amplicon line • The program's validation of the IDT xGen Amplicon CFTR assay and its compatibility with their existing instrumentation and workflows